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Abstract
Several human P5-type transport ATPases are implicated in neurological disorders, but little
is known about their physiological function and properties. Here, we investigated the rela-
tionship between the five mammalian P5 isoforms ATP13A1-5 in a comparative study. We
demonstrated that ATP13A1-4 isoforms undergo autophosphorylation, which is a hallmark
P-type ATPase property that is required for substrate transport. A phylogenetic analysis of
P5 sequences revealed that ATP13A1 represents clade P5A, which is highly conserved
between fungi and animals with one member in each investigated species. The ATP13A2-5
isoforms belong to clade P5B and diversified from one isoform in fungi and primitive animals
to a maximum of four in mammals by successive gene duplication events in vertebrate evo-
lution. We revealed that ATP13A1 localizes in the endoplasmic reticulum (ER) and experi-
mentally demonstrate that ATP13A1 likely contains 12 transmembrane helices. Conversely,
ATP13A2-5 isoforms reside in overlapping compartments of the endosomal system and
likely contain 10 transmembrane helices, similar to what was demonstrated earlier for
ATP13A2. ATP13A1 complemented a deletion of the yeast P5A ATPase SPF1, while none
of ATP13A2-5 could complement either the loss of SPF1 or that of the single P5B ATPase
YPK9 in yeast. Thus, ATP13A1 carries out a basic ER function similar to its yeast counter-
part Spf1p that plays a role in ER related processes like protein folding and processing.
ATP13A2-5 isoforms diversified in mammals and are expressed in the endosomal system
where they may have evolved novel complementary or partially redundant functions. While
most P5-type ATPases are widely expressed, some P5B-type ATPases (ATP13A4 and
ATP13A5) display a more limited tissue distribution in the brain and epithelial glandular
cells, where they may exert specialized functions. At least some P5B isoforms are of vital
importance for the nervous system, since ATP13A2 and ATP13A4 are linked to respectively
Parkinson disease and autism spectrum disorders.
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Introduction
P-type ATPases are intrinsic membrane proteins that couple the hydrolysis of ATP to the
active transport of substrates over biological membranes [1]. The large family of P-type
ATPases comprises five subfamilies (P1-P5) with a total of 36 human isoforms [2]. Phyloge-
netic analysis of P-type ATPase sequences in early genomic sequences revealed the existence of
a fifth P-type ATPase subfamily, which is exclusively found in eukaryotic lineages [2]. How-
ever, the substrate specificity and exact cellular role of the P5-type ATPases remain elusive [1,
3, 4]. So far, various substrates for the P5 ATPases were proposed, ranging from ion transport
(e.g. Ca2+, Mg2+, Mn2+ or Zn2+) to polyamines, sterols or other lipids, but conclusive evidence
has not yet been presented [5–18].
Despite their elusive molecular function, two of the five human P5 ATPases, i.e. ATP13A2
and ATP13A4, have attracted considerable interest as they are implicated in neurological dis-
orders. Loss-of-function mutations in ATP13A2 (PARK9, OMIM 610513) are associated with
the etiology of Kufor-Rakeb syndrome (KRS), a severe juvenile onset autosomal recessive form
of Parkinson Disease (PD) with dementia [19–25], hereditary spastic paraplegia [26] and the
lysosomal storage disorder neuronal ceroid lipofuscinosis [27–30]. In various model organ-
isms and cell systems, ATP13A2 renders protection against well-known genetic and environ-
mental risk factors of PD, such as α-synuclein toxicity [5] and Fe3+- [31], Zn2+- [6, 7, 11] or
Mn2+-toxicity [10, 13, 14, 32, 33], respectively. In addition, ATP13A2 protects against mito-
chondrial stress [7, 14, 15, 34, 35], e.g. induced by complex I inhibition [4, 36, 37].
In one patient with expressive and receptive language delay, the ATP13A4 gene was dis-
rupted by an inversion on chromosome 3q [38]. In addition, several individuals with autism
spectrum disorders carried a mutation in the coding region of the ATP13A4 gene, substituting
D646 for E646 [39]. Two other studies point to a putative link between ATP13A4 and epileptic
encephalopathies [40] or childhood apraxia of speech [41].
The expression pattern of the P5-type ATPases was previously studied in mice. The detec-
tion of Atp13a1 and Atp13a2 mRNAs in all examined mouse tissue points to a housekeeping
function of both isoforms [42], although tissue differences in expression levels may indicate
that they may serve organ-specific functions as well. A particularly high Atp13a2 expression
was found in the brain, whereas Atp13a1 levels were low in the heart. Atp13a3 also showed a
widespread expression, with the highest levels in liver, while Atp13a4 and Atp13a5 expression
was more restricted to brain and stomach [42]. Atp13a1-4 transcripts were differentially
expressed in the cerebral cortex, hippocampus, brainstem and cerebellum and during mouse
development, Atp13a1 and Atp13a2 transcript expression was highest at the peak of neurogen-
esis (E15) [43]. These studies, together with their emerging role in neurological disorders
point to an important function of P5 ATPases in the brain.
Despite their relevance, most of the mammalian P5 isoforms remain largely unexplored
and information on their relationship, molecular properties and subcellular localization is
scarce or non-existing. Therefore, we performed a comparative study to investigate the phylo-
genetic relation, subcellular localization and functional properties of the five mammalian
P5-ATPase isoforms. Based on these results, we describe their evolutionary paths and formu-
late the possible physiological context of this elusive group of primary pumps in animals.
Materials and methods
Phylogenetic analysis
Protein sequences with significant similarity (Expect value <e-30) to the Homo sapiens P5A
ATPase ATP13A1 were first identified using the Basic Local Alignment Search Tool (BLAST)
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for sequences in completed genomes in the NCBI non-redundant protein sequence database
(http://blast.ncbi.nlm.nih.gov/) and in EchinoBase (http://www.echinobase.org/Echinobase/).
P5 ATPases in this dataset were first identified by the presence of fully intact signature motifs
characteristic for P-type ATPases [2] and for P5-type ATPases specifically [44]. This was fur-
ther confirmed by construction of separate phylogenetic trees for all candidate sequences in
each individual genome together with a set of known P-type ATPases including H. sapiens
ATP13A1-5 using first MUSCLE alignment [45] and then by maximum likelihood phylogeny
reconstruction in a Gamma distributed LG model (see below), using MEGA6 software. As
most genomes are still draft versions in the databases, this approach allowed for identification
and removal of duplicates and sequences that do not represent complete proteins. The final
dataset was extended by collecting annotated P5-ATPase sequences from the KEGG database
(http://www.genome.jp/tools-bin/search_sequence?prog=blast&db=cmy&seqid=aa). The
resulting dataset comprised 146 sequences from 43 genomes, which represented different
stages in the evolution of animals. Accession numbers are listed in S1 Table.
Protein alignment of the full-length P5-type ATPases sequences was performed with MUS-
CLE [45]. All positions containing gaps or ambiguous data were eliminated, leaving out a total
of 743 positions in the final data set. The evolutionary history was inferred assuming an LG
[46] + INVGAMMA model, as identified by ProtTest [47]. Phylogenetic analyses were subse-
quently conducted using Bayesian inference and maximum likelihood methods. Bayesian
inference was performed with MrBayes 3.2.6 [48] and maximum likelihood analyses with
RAxML 8.2.9 [49]. MrBayes analysis was performed using the following settings: eight chains
of Markov chain Monte Carlo iterations and heated parameter of 0.05 with trees sampled
every 100 generations. The average standard deviation of split frequencies at termination of
the analysis, after 2,360,000 generations, was 0.009821 for trees in Fig 1 and Fig 2. Branching
was confirmed in a tree based on the same dataset, but including the human Na+/K+-ATPase
(ATP1A1), which was run for 8,000,000 generations and resulted in an average standard devia-
tion of split frequencies of 0.009982, after 7,210,000 generations. The unrooted consensus tree
of the MrBayes analysis was selected for presentation. In the RAxML analysis, clade robustness
was assessed with 100 rapid bootstrap inferences followed by thorough analysis of maximum
likelihood. Bootstrap values were inferred from 1000 replicates to obtain statistical support for
the placement of nodes [50].
DNA constructs
The human hATP13A2-pDONR221 (hATP13A2 splice variant 2) and YPK9-pDONR221 con-
structs were a kind gift of Dr. Lindquist [5]. The yeast SPF1 construct was generated by cloning
the SPF1 cDNA from genomic DNA isolated from the BY4741 wild type strain and inserted
into the pJET1.2 vector (ThermoFisher). The cDNA was further transferred in an XhoI/XbaI
flanked cassette using polymerase chain reaction (PCR) and ligated into the YEp351 vector in
front of the PMA1 constitutive promotor using XhoI/SpeI digestion/ligation. The human hAT-
P13A3-pENTR223.1 construct was purchased from DNASU Plasmid Repository (Arizona,
USA). cDNAs of Atp13a1, Atp13a4 and Atp13a5 were picked up from a mouse brain cDNA
library by PCR and inserted in a Gateway compatible pDONR221 vector. Catalytic dead
mutants of ATP13A1-5, Ypk9p or Spf1p, in which the Asp acceptor residue for the catalytic
autophosphoryation was mutated into an Asn, were created via site-directed mutagenesis
(Quickchange II XL Site-directed mutagenesis, Stratagene). N-terminal constructs of ATP13A1
(Mb-Ma, 197 amino acids or Mb, 95 amino acids) and ATP13A2 splice variant 2 (Ma-M1, 251
amino acids or Ma, 187 amino acids) were generated via PCR. Constructs were subsequently
transferred via the Gateway system (LifeTechnologies) to mammalian (pcDNA3.1, pcDNA6.2)
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or yeast (pAG425GDP and YEp351, which were made gateway compatible using the supplier’s
instructions) expression vectors containing N- or C-terminal GFP- or mCherry-tags or no tag
in the case of YEp351. To produce tagged Ypk9p proteins for purification (Ypk9p WT and
Ypk9p D781N), the cDNA was cloned from the pDONR221 plasmids using PCR cloning and
placed in front of a GAL10 promotor in a yeast episomal vector (pRS423). A FLAG/RGS10xhis
purification tag was inserted at the 5’ end of the cDNA by incorporating its coding sequence
into the primers. All constructs were verified by sequencing.
Cell culture
COS-8 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) containing 10%
Fetal Calf Serum (FCS), 4 mM GlutaMAXTM-I supplement, 100 U Penicillin/ml, 100 μg Strep-
tomycin/ml and 0,1 mM MEM non-essential amino acids (Invitrogen) at 37˚C in an atmo-
sphere of air with 10% CO2. HeLa cells (human cervix adenocarcinoma cell line) were cultured
in DMEM containing 10% FCS, 4 mM GlutaMAXTM-I supplement, 100 U Penicillin/ml, 100 μg
Streptomycin/ml (Invitrogen) at 37˚C in an atmosphere of air with 5% CO2. MEF (mouse
embryonic fibroblast) and Neuro2a (mouse neuroblastoma) cells were cultured in DMEM/F-12
containing 10% FCS, 4 mM GlutaMAXTM-I supplement, 100 U Penicillin/ml, 100 μg Strepto-
mycin/ml. Transfections were performed using GeneJuice (Novagen) according to the manu-
facturer’s protocol. Briefly, cells were split in 15 cm ø Petri dishes (4.1 106 cells/dish), chamber
slides (20.000 cells/chamber) or 12-well plates (20.000 cells/well) and after 24 h, transfections
were performed using a concentration of 3 μl GeneJuice per μg DNA. 48 h after transfection,
cells were harvested, examined under the microscope or prepared for immunostaining.
Generation of an ATP13A1 antibody
An ATP13A1 antibody (SY2459) was generated against the peptide 543RGVAGLRDG-
KEVTPVc, which was conjugated to keyhole limpet hemocyanin (KHL). The antibody was
produced by Eurogentec with the Rabit DX Speedy– 28-day immunization protocol (4 injec-
tions, 3 bleeds) and affinity purified.
Immunoblotting
15 cm ø Petri dishes of transiently transfected COS-8 cells were harvested 48 h post transfec-
tion. Subcellular fractions were obtained after differential centrifugation as previously
described [37]: the nuclear fraction (1,000 g, 10 min, 4˚C), the mitochondrial/lysosomal frac-
tion (12,000 g, 20 min, 4˚C) and the microsomal fraction (200,000 g, 35 min, 4˚C). To prepare
total membrane fractions, the nuclear fraction was removed (1,000 g, 10 min, 4˚C) and the
remaining lysate was centrifuged for 35 min at 200,000 g (4˚C). Pellets were suspended in 0.25
M sucrose supplemented with protease inhibitors (SigmaFast, Sigma). Protein concentrations
were determined via the Qubit fluorometric method (LifeTechnologies).
Immunoblotting was performed as previously described [37]. Membranes were probed
with primary rabbit polyclonal antibodies directed against ATP13A1 (SY2559, homemade) or
Fig 1. Phylogenetic analysis of the P5-type ATPases. Phylogenetic tree of 146 protein sequences of P5-type ATPases as inferred from the combined output of
two independent statistical methods of measurement (Bayesian inference and maximum likelihood analysis, see materials and methods for a detailed
description). Yellow and blue shades represent sequences from protostomia and deuterostomia, respectively. Black dots represent Bayesian inference values of
1.00 and numbers noted at key nodes are represented with Bayesian inference statistical values on the left and maximum likelihood statistical values on the right
of the dash (left/right). Accession numbers of named sequences can be found in S1 Table. Positions of human and model animal organisms (C. elegans, D.
melanogaster, D. rerio, M. musculus) are marked by # and , respectively. Yeast sequences are marked by ‡. The meaning of the colored arrows is provided in the
description of the main text. The yellow numbers indicate the three major P5B gene duplications in vertebrate evolution as discussed in the main text.
https://doi.org/10.1371/journal.pone.0193228.g001
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ATP13A2 (SY3072, homemade [37] or A3361, Sigma) or with a mouse monoclonal antibody
directed against mCherry (AB125096, Abcam) or GAPDH (G8795, Sigma). Proteins were
Fig 2. P5-type ATPase phylogenetic tree. Simplified view of the phylogenetic tree calculated in Fig 1. The P5A group includes only ATP13A1-like sequences
(grey), while the P5B group includes subclades belonging to the ATP13A2 (blue), P5Binv (purple, invertebrate P5B), ATP13A3 (yellow), ATP13A4 (red) and
ATP13A5 (green) clades. Sequences from cnidaria, placozoa and ctenophore are marked in white dots. Invertebrate sequences are marked in yellow dots.
Sequences from hemichordates and echinoderms are marked with light blue dots and sequences from higher vertebrates are marked in progressively darker
shaded blue dots. Yeast Spf1p and Ypk9p are marked with red dots. The yellow numbers indicate the three major P5B gene duplications in vertebrate
evolution as discussed in the main text.
https://doi.org/10.1371/journal.pone.0193228.g002
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detected using enhanced chemiluminescence (SupersignalTM West Pico, LifeTechnologies)
and the ChemiDocTM MP Imager (Bio-Rad). For detection of Ypk9p a monoclonal anti-FLAG
antibody was used (F3165, Sigma) which was recognized by an anti-mouse antibody coupled
to alkaline phosphatase (A4312, Sigma).
Immunocytochemistry and fluorescence microscopy
For co-localization experiments, HeLa, MEF or Neuro2a cells were transiently co-transfected
with fusion proteins of the different P5 isoforms (N- or C-terminal GFP- or mCherry-tagged)
and different cellular markers (SERCA2b, Rab4/5/7/11, CLC-7 and Lamp1) in chamber slides.
48 h post transfection, cells were visualized with an Olympus IX81 fluorescence microscope
using a 63x oil immersion objective as previously described in [37].
Immunocytochemistry experiments were performed on transiently transfected HeLa
cells, cultured on gelatine-coated glass coverslips in 12-well plates. Cells were co-trans-
fected with ATP13 A1 or ATP13A2 in combination with the different cellular markers. 48
h post transfection, cells were washed in PBS, fixed in 4% paraformaldehyde in PBS for 20
min and subsequently permeabilized with 0.1% Triton X-100 in PBS for 4 min at room
temperature. Blocking was performed for 1 h with 5% goat serum and 1% BSA in PBS. Pri-
mary homemade antibodies (ATP13A1, 1/500) or commercial antibodies (1/200; lamp1,
Abcam ab25630; lamp2, Abcam ab25631; CD63, Exbio Praha 11-343-C100) and Alexa
Fluor labeled secondary antibodies (1/2000) were diluted in 1% BSA in PBS. Glass cover-
slips were mounted on a microscope slide using FluorSafeTM reagent (Calbiochem) and
visualized with the Olympus IX81 fluorescence microscope or a Zeiss LSM510 confocal
microscope. The Pearson’s correlation coefficient was determined with ImageJ software
(NIH, Bethesda, Maryland, USA), using the JACoP plug-in [51].
For expression and localization of Ypk9p and ATP13A1-5 in yeast, constructs were inserted
into the pAG425 vector containing an N- or C-terminal GFP fusion. spf1- and ypk9- deletion
strains of Saccharomyces cerevisiae BY4741 (MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; yel039w::
kanMX4 / MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; yor291w::HIS3) were transformed using
the Li-acetate method and positive transformants were selected on synthetic complete dextrose
agar plates (SCD-L; 2% glucose, 0.7% yeast nitrogen base, complete synthetic medium without
leucine, 2% agar, 50 mM succinic acid-Tris pH = 5.5). Positive transformants were grown for
24 h on selective media conditions before dilution in 0.2% agar onto microscopy cover slides
and subsequently visualized. Images were obtained using a Leica TCS SP5-X UV confocal laser
scanning microscope with a 63x/1.20 numerical aperture water immersion objective (Leica
Microsystems). GFP was excited at 488 nm and the emitting light was measured in the interval
500–533 nm. Brightfield and fluorescent images were processed using Leica software (Leica
Microsystems). The contrast of the images was adjusted in a nonlinear manner to achieve
qualitatively comparable signals for localization.
Fluorescence protease protection (FPP) assay
HeLa cells were transiently transfected with N- or C-terminal GFP fusion proteins of
ATP13A1-4 (WT or truncation mutants) and subjected to FPP as previously described [37,
52]. The minimal effective digitonin (Sigma, D141) concentration (20–40 μM), optimal time
of digitonin treatment (30–90 s) and minimal effective trypsin concentration (100–150 μg/ml)
were determined for each experiment in cells expressing GFP (cytosolic control protein) or
ERO-GFP (ER luminal control protein) [37].
Relationship between the five mammalian P5 ATPases (ATP13A1-5)
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Expression and purification of yeast Ypk9p
For overexpression of Ypk9p and Ypk9p D781N, ypk9- cells were transformed with the overex-
pression plasmids (pRS423-pGAL10) using the Li-acetate method as described above. Both
constructs encoded for a combined FLAG-RGS10xHis tag in the N-terminus of the proteins.
Positive transformants were inoculated in 10 ml startup cultures (SCD-H; 2% glucose, 0.7%
yeast nitrogen base, complete synthetic medium without histidine, 50 mM succinic acid-Tris
pH = 5.5) overnight and transferred to 100 ml cultures grown for 12 hours at 30˚C and 150
rpm (SCD-H). Samples were harvested by centrifugation and washed twice in sterile H2O
before resuspension in 100 ml rich media (1% yeast extract, 2% bactopeptone supplemented
with either 2% glucose (YPD) or 2% galactose (YPG)). Induction (YPG) or repression (YPD)
of expression followed during growth for 16 hours at 30˚C and 150 rpm. Finally, cells were
harvested by centrifugation, washed twice in sterile H2O and frozen in liquid N2 and stored at
-80˚C.
Total membranes were purified by resuspending thawed cells at a 3:1 ratio (w/w) in lysis
buffer (50 mM Tris, 1 mM EDTA, 0.6 M Sorbitol, 250 μl PMSF, 1 mM dithiothreitol (DTT),
2 μg/ml Pepstatin A, pH 7.5 with HCl). Glassbeads were added to half volume and the cells
were lysed by vortexing for 16 cycles of 30 s with 30 s in between on ice. Samples were centri-
fuged for 15 min 1,000 g at 4˚C and the supernatant was isolated and centrifuged again for 1 h
at 160,000 g, 4˚C. The pellet consisting of total membranes was resuspended in solubilization
buffer and homogenized using a glass piston in a glass tube. Total protein was determined by
Bradford assay and aliquots were frozen in liquid N2 and stored at -80˚C. For purification of
tagged Ypk9p and Ypk9p D781N proteins, total membranes were solubilized in solubilization
buffer (20 mM MOPS, 130 mM KCl, 20% glycerol, 2 μg/ml pepstatin A, 1 mM DTT, 250 μM
PMSF, pH 7.4 N-methyl-D-glucamine) supplemented with 5 mM imidazole and detergent n-
Dodecyl β-D-maltoside (DDM) at a ratio of 2:1 with the total protein amount. Samples were
incubated for 1 h with gentle rotation at 4˚C. Following ultracentrifugation for 1 h 100,000 g at
4˚C the supernatant was allowed to equilibrate for 2 h in a head over head rotator at 4˚C with
Ni-NTA (nitrilotriacetic acid) resin (Sigma) column, which had been pre-equilibrated with 4
column volumes (Cv) of binding buffer containing half the concentration of DDM used for
solubilization. Washes were performed two times with 3x Cv of binding buffer supplemented
with 10 mM imidazole and 0.05% DDM, and two times with 1.5x Cv of binding buffer supple-
mented with 20 mM imidazole and 0.05% DDM. Elution was performed using binding buffer
supplemented with 300 mM imidazole and 0.005% DDM and collected in fractions of 250 μl.
12 μl of each fraction was used for SDS-PAGE following protein staining with Coomassie Blue.
The protein concentration was determined by a Badford assay using γ-globulin as a standard.
Autophosphorylation assay
Autophosphorylation of mCherry labeled ATP13A1-5 was performed as described in [37]. EP
reaction buffer (17 mM Hepes pH 6.5, 160 mM KCl, 2 mM MgCl2, 1 mM DTT, 5 mM NaN3)
was added to 40 μg of COS-8 membranes to a final volume of 95 μl. The reaction was initiated
on ice by adding [γ-32P] ATP (2 μCi; 5.125 μM), 5.1 μM cold ATP. 400 μl stop solution (20%
trichloroacetic acid, 10 mM phosphoric acid) was added after 5 min to stop the reaction. Sam-
ples were precipitated on ice for 20 min and centrifuged (20,000 g, 30 min, 4˚C). Pellets were
washed twice with 400 μl ice-cold stop solution and dissolved in sample buffer prior to acidic
electrophoresis as previously described [12]. For measurements of Ypk9p and Ypk9p D781N
activity the purified proteins were reactivated with a yeast polar lipid extract (Avanti) at a 1/
3.55 protein to lipid ratio in reactivation buffer (50 mM Tris, 50 mM NaCl, 0.5% octyl β-D-glu-
copyranoside) by gently mixing protein and lipids dissolved in detergent following incubation
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for 30 min on ice. Autophosphorylation of the reactivated enzymes was performed essentially
as described in [12] using the reaction buffer noted above. Samples were measured and quanti-
fied using scintillation counting in comparison to a ATP32 standard.
Yeast complementation
Wild-type and knockout strains of S. cerevisiae BY4741 (WT—MATa: his3Δ1; leu2Δ0;
met15Δ0;ura3Δ0; spf1- - MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0: yel039w::kanMX4 and ypk9-
- MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; yor291w::HIS3) were transformed with the indi-
cated constructs in the YEp351 vector using the Li-acetate method and positive transformants
were selected on synthetic complete dextrose agar plates (SCD-L; 2% glucose, 0.7% yeast nitro-
gen base, complete synthetic medium without leucine, 2% agar, 50 mM succinic acid-Tris
pH = 5.5). Transformed cells were grown overnight on SCD-L plates, suspended in sterile
milliQ water and diluted to OD600 = 1. A dilution series of OD600 = 1, 0.1, and 0.01 was
made with sterile milliQ water, and 5 μl of each dilution was spotted onto YPD plates (1%
yeast extract, 2% bactopeptone, 2% galactose, 2% agar) or SCD-L plates containing caffeine or
MnCl2 at indicated concentrations. Growth was recorded after 2 days at 30˚C.
Results
Phylogenetic and functional relationship of the mammalian P5-type
isoforms
To explore the relationship between the mammalian P5-type ATPase isoforms, we performed
a phylogenetic analysis of 146 animal P5 ATPase sequences belonging to 22 different phyla
across 43 individual organisms (including human ATP13A1-5). We included the yeast Spf1p
and Ypk9p as more distant fungal representatives (S1 Table). The sequences were aligned and
subsequently subjected to a phylogenetic analysis based on both the Bayesian inference and
maximum likelihood methods, which provides superior statistics as compared to previous
phylogenetic approaches that were used to compare the P5-ATPases in eukaryotes [44, 53].
The resulting phylogenetic model provides strong support for a strict division of the animal P5
ATPases into P5A and P5B groups (Figs 1 and 2 and S1 Fig), confirming previous work [44,
53].
All organisms tested had only a single P5A ATPase with one exception, namely Salmo salar
(black arrow Fig 1). S. salar harbors two closely related P5A ATPase sequences, most likely
reflecting a recent gene duplication in this species. The P5A sequences, which include the
human ATP13A1 isoform, grouped together into a single monophyletic clade with Spf1p at its
base (Figs 1 and 2).
The single yeast P5B isoform Ypk9p is found at the bottom of the P5B tree together with
sequences of primitive animals such as the porifera Amphimedon queenslandica and the cni-
darian Mnemiopsis leidyi, where also only one P5B isoform is found (red arrow Fig 1). This
suggests that the fungal and early animal P5B sequences may be closely related. In contrast, all
analyzed mammalian genomes contain four P5B ATPases, which belong to separate, isoform-
specific clades that include related sequences from all other mammals. Homo sapiens
ATP13A2, ATP13A3, ATP13A4, and ATP13A5 each belong to one of these isoform specific
clades, which have been named accordingly (Figs 1 and 2). The isoform specific clades are a
strong indication that the diversification into four isoforms occurred early in animal evolution,
and/or that shortly following a gene duplication event a rapid diversification may have taken
place. Interestingly, a fifth P5B clade (P5BINV clade) appeared to be specific for invertebrates
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(protostomes) (Figs 1 and 2) and branched out at the base of the tree close to the ATP13A2
and ATP13A3 clades.
ATP13A2 and ATP13A3 presumably duplicated from a common P5B ancestor gene in the
animal deuterostome lineage (yellow number 1, Figs 1 and 2), although the precise origin of
the duplication is difficult to pinpoint (Fig 2, yellow number 1). The long evolutionary separa-
tion between ATP13A2 and ATP13A3 resulted in significant sequence diversity and two
clearly separated clades. ATP13A2 may correspond more closely to invertebrate P5B ortholo-
gues than ATP13A3, since the ATP13A2 clade also includes some invertebrate sequences
(green arrow Fig 1), while the ATP13A3 clade only includes vertebrate sequences. Remarkably,
the ATP13A3-like sequences in the vertebrate lineage starting with early deuterostomes like
echinoderms and primitive chordates (hemichordate and tunicate) (blue arrow Fig 1), appear
to originate from a common ancestor of ATP13A3, despite that ATP13A2 may correspond
more closely to the invertebrate P5Bs (Fig 1). With strong statistical support, the ATP13A4
and ATP13A5 clades evolved in higher vertebrates from two successive gene duplications of
ATP13A3 (yellow numbers 2–3 in Figs 1 and 2), revealing a close relationship between the ver-
tebrate isoforms ATP13A3-5. Only amniotes (reptiles, birds and mammals) contain two sepa-
rate isoforms ATP13A4 and ATP13A5, while immediately before the split between ATP13A4
and ATP13A5, only a single ATP13A4-like sequence is recognized in the coelacanth Latimeria
chalumnae and the amphibia Xenopus laevis (Figs 1 and 2). This suggests that a gene duplica-
tion of ATP13A4 took place before the rise of the reptiles (yellow number 3 in Figs 1 and 2),
while ATP13A3 duplicated in the evolution of lobe-finned fish giving rise to the common pro-
genitor of ATP13A4 and ATP13A5 (yellow number 2 in Figs 1 and 2).
In conclusion, the P5A ATPases did not diversify in animals, whereas the P5B ATPases
diversified as the result of sequential gene duplications: one that occurred before the split
between invertebrates and vertebrates, one that occurred after the split between ray-finned
and lobe-finned fishes, and one between amphibia and reptilia evolution (Figs 1 and 2 and S1
Fig). This suggests that P5A ATPases may have a general and highly conserved function,
whereas during vertebrate evolution P5B ATPases may have diversified to take up more spe-
cialized tissue-specific and/or subcellular functions.
An analysis of publicly available human microarray data (Genevestigator [54]) revealed that
the P5A ATPase ATP13A1 is generally expressed in all cell types of H. sapiens, whereas the
human P5B ATPases indeed show a more tissue specific expression pattern (S2 Fig). Although
expressed in most tissues, ATP13A2 appears to be most highly expressed in the brain, which is
also corroborated by a previous analysis of P5 ATPase gene expression in the mouse [42]. Also
the ATP13A3 gene displays a broad expression pattern, while ATP13A4 and ATP13A5 are
highly expressed in specialized epithelial glandular cells. These are mainly associated with the
lung (both ATP13A4 and ATP13A5—alveolar type 2 cells), mouth (ATP13A4—oral cavity,
mucosa and gingiva) or nose (ATP13A5—nasal epithelium), but also sexual organs (ATP13A4
in mammary glands and ATP13A5 in testis epididymal corpus) (S2C and S2D Fig). In mice,
the expression of the ATP13A3 gene appears to be highly promoted during early embryonic
development in contrast to mainly postnatal expression of ATP13A4 and ATP13A5 (S2B Fig).
Mammalian P5-type proteins are bona fide P-type ATPases displaying
autophosphorylation
We previously demonstrated that in isolated membrane fractions hATP13A2 undergoes
autophosphorylation on the acceptor residue D508 [37]. This aspartyl phosphorylation is a
hallmark feature of P-type ATPase functionality. We now explored whether other P5A- and
P5B-type ATPases may undergo autophosphorylation to compare the relationship of P5-type
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ATPases at the biochemical level. We confirmed that ATP13A1-5 isoforms contain the typical
P-type ATPase sequence motifs for coupled transport, which involves catalytic autophosphor-
ylation on a conserved Asp residue [2]. While ATP13A2 and ATP13A3 cDNA was already
available, we first cloned the cDNA of the ATP13A1, 4 and 5 isoforms from a mouse brain
mRNA preparation. We then assessed the autophosphorylation activity of N-terminal
mCherry labeled P5 constructs in a COS-8 overexpression system (Fig 3) [37]. Like ATP13A2,
we now showed that also the mammalian P5A-type ATPase ATP13A1 is autophosphorylated
(EP32, Fig 3A–3D). No traces of a phospho-intermediate were observed for the ATP13A1
D530N mutant, which cannot be solely attributed to the approximately three-fold lower
expression levels of the mutant versus WT (mCherry immunostaining, Fig 3A). The
mATP13A1 and hATP13A2 phosphoproteins were highly sensitive towards hydroxylamine,
which is a characteristic of aspartyl phosphorylation in P-type ATPases (Fig 3B) [55]. Hydrox-
ylamine chemically attacks phosphorylated Asp residues, while leaving phosphorylated Ser,
Thr or Tyr residues intact. Thus, the hydroxylamine sensitivity of the phosphorylated bands,
together with the loss of phosphorylation in the D530N mutant prove that autophosphoryla-
tion of ATP13A1 takes place on the conserved D530 in the P-type ATPase signature motif.
We also observed autophosphorylation of hATP13A3 and mATP13A4 (Fig 3C and 3D),
although only in four out of eight independent membrane preparations, which limited further
biochemical analysis with hydroxylamine. Several parameters such as cell density, passage
number, degree of transient transfection, availability of the substrate and cellular stress condi-
tions may possibly contribute to this variable behavior. In none of the eight independent prep-
arations, we detected autophosphorylation of ATP13A5, despite sufficiently high expression
(Fig 3C).
Compared to the mammalian P5-type ATPases also the two S. cerevisiae P5-type ATPases
Spf1p and Ypk9p contain the highly conserved P-type ATPase sequence motifs required for
transport. Autophosphorylation was previously reported for Spf1p, which takes place on the
Asp487 residue in the autophosphorylation motif [56]. To produce Ypk9p protein for bio-
chemical assays we purified 10xHis-FLAG tagged versions of Ypk9p and the catalytic dead
mutant Ypk9p (D781N) from overexpression in yeast (Fig 3E and 3F, and S3 Fig) and could
demonstrate that Ypk9p undergoes autophosphorylation, which is impaired by a mutation of
the catalytic Asp781 residue in the P-type motif for autophosphorylation (Fig 3F).
In conclusion, we have demonstrated autophosphorylation on the catalytic Asp residue of
ATP13A1 and ATP13A2, while we observed indications for autophosphorylation of ATP13A3
and ATP13A4. Thus, several mammalian and yeast P5A- and P5B-type ATPase isoforms dis-
play the typical characteristics for autophosphorylation, which may represent a hallmark of
P5-type ATPases.
ATP13A1 is an endoplasmic reticulum-localized pump with 12
transmembrane helices
The different P5A and P5B isoforms in vertebrates may not only fulfill tissue specific functions
(S2 Fig), but may also be targeted to various subcellular compartments where they may exert
dedicated cellular functions. To explore this possibility, we compared the subcellular distribu-
tion of the five mammalian isoforms ATP13A1-5 in several cell types (Figs 4 and 5). We gener-
ated GFP- and mCherry-tagged constructs for all P5B isoforms, which were co-expressed in
HeLa, Neuro2a or MEF cells with various tagged marker proteins for confocal microscopy
studies. The data below (Figs 4 and 5) represent images of HeLa cells, but we confirmed a simi-
lar targeting pattern in Neuro2a and MEF cells for all constructs (data not shown).
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Fig 3. Auto-phosphorylation of the P5-type ATPases. A-C. Microsomal fractions of COS-8 cells, transiently overexpressing WT of dead mutants of the
P5-isoforms (N-mCherry-tag) were analyzed on immunoblot or radiogram (EP32) to examine respectively expression levels and autophosphorylation. As a
control, non-transfected cells (NT) were included. A. Immunoblot with mCherry antibody shows overexpression for ATP13A1 and ATP13A2 WT and
dead mutants. GAPDH levels were determined as loading control. The radiogram (EP32) demonstrates phosphorylation for WT ATP13A1 and ATP13A2,
but not for dead mutants. B. Radiogram indicates that ATP13A1 and ATP13A2 are both sensitive towards hydroxylamine (HA), a hallmark of P-type
ATPases. HA quenches the phosphorylated Asp residues, but leaves phosphorylated Thr, Ser or Tyr residues intact. The lower panel shows a coomassie
stained gel that depicts the equal loading for all lanes in the upper panel. C. Immunoblot and radiogram of the autophosphorylated intermediates (EP32) of
the five P5 isoforms demonstrate overexpression of all isoforms, whereas phosphorylation was only seen for ATP13A1-4. D. Graph showing the
autophosphorylated levels (EP32 panel C) normalized to the relative expression levels of each isoform (mCherry immunoblot panel C). Results indicate
strongest autophosphorylation for ATP13A1, ATP13A2 and ATP13A3. ATP13A4 displays low autophosphorylation levels, while ATP13A5 levels are
negligible. Data are represented as average ± SD (n = 4). , P 0.05 versus ATP13A1 and ATP13A2; #, P 0.05 versus ATP13A1, ATP13A2 and ATP13A3
(one-way ANOVA, Bonferroni post-hoc). E. Immunoblot demonstrating the expression of the N-terminal 10xHis-FLAG tagged versions of the yeast
Ypk9p and Ypk9p (D781N) in yeast total membrane fractions. Antibody against the FLAG part of the tag was used to visualize protein expression and
GAPDH was used as a loading control. The wildtype but not catalytic dead protein was able to complement loss of the native YPK9 gene (Fig 6B). Both
Ypk9p variants were successfully purified using the 10xHis part of the tag (see S3 Fig). Proteins are expressed from the galactose inducible promotor when
grown in rich media supplemented with galactose (YP-Gal) while glucose repress expression (YP-Glu). F. Quantification of Ypk9p autophosphorylation
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mATP13A1-GFP (Fig 4A, WT and D530N mutant) co-localized well with SERCA2b, a
well-characterized endoplasmic reticulum (ER) P-type ATPase [57] (Pearson’s correlation
coefficient (PCC) of 0.827 ± 0.079). In contrast, we observed no co-localization with the Golgi/
Secretory Pathway Ca2+ ATPase or various endosomal markers (RAB4, 5, 7 and 11) (data not
shown). We also tested whether the position or presence of a fluorescent tag may affect the
localization. Both N- and C-terminal GFP fusion constructs were found in the ER (Fig 4A and
4B) and we confirmed with a homemade polyclonal antibody raised against mATP13A1 (S4
Fig) that also the unlabeled mATP13A1 remains in the ER (Fig 4C). Also, the catalytically inac-
tive mutant of mATP13A1 (D530N) colocalizes with SERCA2b, indicating that the transport
activity doesn’t influence the localization (S5A Fig). Although we confirmed that mATP13A1
is expressed at the mRNA level, we were unable to detect the endogenous mATP13A1 protein,
possibly because of the low abundance of the endogenous protein or the low affinity of the
antibody.
Compared to most other mammalian P-type ATPases that typically contain 10 TM helices,
topology predictions suggest that on top of the typical 10 TM helices, ATP13A1 may contain
an additional N-terminal hairpin [53]. We experimentally confirmed the existence of this N-
terminal hairpin by a fluorescence protease protection (FPP) assay [52], which is a widely
accepted method to study topology, which was used before to establish the topology of
ATP13A2 [37]. We performed an FPP assay on full-length ATP13A1 and N-terminal con-
structs fused to GFP at various positions (S6 Fig). The protection of the GFP tag against trypsin
cleavage indicates a luminal position of the GFP tag (as with the ER-localized ERO-GFP),
while the quenching of the signal reflects a cytosolic position (as with the cytosolic GFP). Our
data show that ATP13A1 contains an N-terminal hairpin in addition to the 10 predicted TM
helices that are conserved amongst P-type ATPases. It is unlikely that the GFP tag may disrupt
using scintillation counting, normalized to μg of purified Ypk9p. Purified Ypk9p was able to undergo autophosphorylation, which was abolished by
mutating the Asp residue in the catalytic motif (D781N).
https://doi.org/10.1371/journal.pone.0193228.g003
Fig 4. ATP13A1 localizes to the endoplasmic reticulum. HeLa cells were transiently co-transfected with ATP13A1
wildtype (no tag, N- or C-terminal GFP-tag) or dead mutant (N-terminal GFP-tag) and SERCA2b-mCherry, an ER
resident. A-C. ATP13A1 with N- (A) or C-terminal (B) GFP-tag or unlabeled ATP13A1 (C) co-localizes with
SERCA2b. Unlabeled ATP13A1 was detected via immunocytochemistry with homemade ATP13A1 antibody (S4 Fig)
and Alexa Fluor 488. Scale bar represents 20 μm.
https://doi.org/10.1371/journal.pone.0193228.g004
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the topology, since N- and C-labeled ATP13A1 proteins remain active (Fig 3A, and also S8 Fig
as explained below).
Thus, we demonstrate that mATP13A1, the mammalian P5A representative, is an ER resi-
dent protein that most likely contains 12 TM helices, which would be in line with earlier topol-
ogy predictions [53].
Mammalian P5B ATPases target to late endo-/lysosomes and contain an
even number of TM helices
For the localization of the P5B-ATPases, we turned to N-terminal mCherry labeled ATP13A2-
5 constructs. No clear signs of organelle abnormalities or cell toxicity were found as a conse-
quence of overexpressing the P5B isoforms. We first confirmed that the localization of
mCherry labeled ATP13A2 corresponds with previous reports (Fig 5T) [11, 19, 37]. Indeed,
we observed co-localization with GFP-labeled markers RAB7 (Fig 5B, late endo-/lysosomes),
while the overlap with RAB5 (Fig 5A, early endosomes) or RAB11 (Fig 5C, recycling endo-
somes) was lower. Also, the unlabeled catalytically inactive mutant of hATP13A2 (D508N) is
found in the late endo-/lysosomes indicating that the transport activity or tag has no impact
on the localization (S5B Fig). Via immunocytochemistry we confirmed that ATP13A2 co-
localized well with endogenous markers of the late endosomal compartment, CD63 (Fig 5E
and 5F), and lysosomes, lamp2 (Fig 5D), which is consistent with previous reports [11, 19, 37].
Importantly, we also observed a similar distribution for the N- or C-terminal fusion proteins
of ATP13A2, indicating that the position of the tag has no effect on the localization (Fig 5E, 5F
and 5W), as highlighted before [37].
The mCherry labeled hATP13A3 constructs overlapped to some degree with several
GFP-labeled markers of the early (Fig 5G) and late endo-/lysosomes (Fig 5H), but the best
co-localization was observed with markers of the recycling endosomes (Fig 5I). We con-
firmed by immunolocalization a lower overlap of ATP13A3 with endogenous markers of
the late endosomes (Fig 5K and 5L) and lysosomes (Fig 5J). Finally, the localization of the
N- or C-terminal labeled ATP13A3 was similar (Fig 5K, 5L and 5W), and also GFP-labeled
ATP13A3 constructs displayed a comparable subcellular distribution (S7D and S7E Fig).
Together, our results indicate that in the overexpression system ATP13A3 is mainly tar-
geted to the recycling endosomes, and to a lesser extent to the late endo-/lysosomal com-
partment (Fig 5U).
For ATP13A4, we observed a broader overlap with various GFP labeled markers of the
endosomal compartment (Fig 5V): RAB5 (Fig 5M), RAB7 (Fig 5N) and RAB11 (Fig 5O). Via
immunolocalization with endogenous markers, we found a similar degree of overlap with
CD63 (Fig 5Q and 5R) as for RAB7 (Fig 5N), while the overlap with lysosomes is lower (Fig
5P). Little effect of the position of the tag is observed (Fig 5Q, 5R and 5W), and also the GFP-
labeled ATP13A4 constructs display a similar subcellular distribution (S7B and S7C Fig).
Fig 5. ATP13A2-4 localize to the endo-/lysosomal system. HeLa cells were transiently co-transfected with hATP13A2, hATP13A3, mATP13A4 or
mATP13A5 (N- or C-terminal mCherry-tag, N-mCh and C-mCh, respectively). Scale bar represents 20 μm. A-C. Co-localization of hATP13A2 (N-terminal
mCherry-tag) with various GFP-labeled markers, such as the early endosomal marker RAB5 (A), the late endo-/lysosomal marker RAB7 (B) and RAB11, a
marker for the recycling endosomes (C). D-F. Immunocytochemistry of cells overexpressing N- or C-terminal mCherry labeled hATP13A2 with the
endogenous markers of late endosomes (CD63, E-F) and lysosomes (lamp2, D). G-I. Co-localization of hATP13A3 with GFP-labeled RAB5 (G), RAB7 (H)
and RAB11 (I). J-L. Immunocytochemistry of cells overexpressing N- or C-terminal mCherry labeled hATP13A3 with the endogenous markers of late endo-/
lysosomes lamp1 (K, L) and of lysosomes lamp2 (J). M-O. Co-localization of hATP13A4 with GFP-labeled RAB5 (M), RAB7 (N) and RAB11 (O). P-R.
Immunocytochemistry of cells overexpressing N- or C-terminal mCherry labeled hATP13A4 with the endogenous markers of late endosomes (CD63, Q-R)
and lysosomes (lamp2, P). S. mATP13A5 overexpression is too weak for fluorescence microscopy. When a fluorescent signal is observed, an endosomal-like
pattern was seen in 80% of the observations (two left panels), whereas in other images a reticular pattern was observed (right panel). T-W. Bar graphs depict
Pearson’s coefficients (PCC) of ATP13A2-5 isoforms with various endosomal markers.
https://doi.org/10.1371/journal.pone.0193228.g005
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Unfortunately, we were unable to unambiguously determine the localization of ATP13A5,
although we tested various tags on mATP13A5 (V5, GFP and mCherry either on the N- or C-
terminus) and expression in different cell types (COS-8, MEF, HeLa and Neuro2a) (data not
shown). The low percentage of fluorescently labeled HeLa cells mainly displayed a vesicular
pattern (Fig 5S), but co-expression with endosomal markers failed. Moreover, we often
observed a more reticular ER-like distribution pattern for mATP13A5 in the transfected popu-
lation, which could indicate that the expressed protein had problems leaving the ER (different
panels of Fig 5S).
Earlier topology predictions indicated that all P5B ATPases contain an unusual N-terminal
membrane segment (Ma) that may represent an extra TM region at the N-terminus, resulting
in a total number of 11 TM helices [53]. However, we recently demonstrated with an FPP
assay that hATP13A2 consists of an even number of TM regions and that the unusual N-termi-
nal hydrophobic segment (Ma) does not span the membrane. Thus, experimental verification
of the topology predictions is important [37] (S7A Fig). Here, we established that like
ATP13A2, also ATP13A3 and ATP13A4 display an even number of TM helices, which further
refutes the earlier P5B topology predictions [53]. Indeed, both the N- and C-termini of GFP-
labeled hATP13A3 (S7B and S7C Fig) and mATP13A4 (S7D and S7E Fig) are cytosolic, since
the fluorescent tag is sensitive to trypsin degradation. Note that the N- or C-terminal addition
of fluorescent tags did not prevent the exit of ATP13A2-4 from the ER. Also the autophopho-
sphorylation activity of N-terminal labeled protein remains intact (Fig 3C and 3D). Together,
this indicates that the fusion proteins are properly folded and that the topology is intact. Based
on these FPP data and the strong conservation of the N-terminal Ma segment in all P5B-AT-
Pases, we expect that like ATP13A2, also other P5B-ATPases contain an N-terminal mem-
brane associated fragment.
In conclusion, our data support the division of mammalian P5 type ATPases into a P5A
and P5B group. mATP13A1 represents an ER resident protein with most likely 12 TM helices,
while ATP13A2-4 reside mainly in overlapping compartments of the endosomal system and
present a membrane topology that differs from ATP13A1.
The mammalian P5A isoform ATP13A1 complements the yeast P5A
deletion mutant
Next, we assessed the functional and physiological relationship between yeast and mammalian
P5-type ATPases via a yeast complementation assay. Similar to the re-introduction of SPF1,
expression of the human P5A isoform ATP13A1 rescued the impaired growth of the spf1- dele-
tion strain on caffeine (Fig 6A). Autophosphorylation deficient D/N mutants of Spf1p (Fig 6A)
and ATP13A1 (Fig 6C) were not functional. We further demonstrate that the N-GFP and
C-GFP labeled ATP13A1 constructs are targeted to the ER (Fig 6E), like in mammalian cells
(Fig 4), and functionally complement the yeast spf1- phenotype (S8 Fig). This strongly indi-
cates that the addition of fluorescent tags does not disrupt the function, topology or subcellular
localization of ATP13A1. The complementation by an animal P5A ATPase gene of a fungal
orthologue points to a highly conserved function of P5A ATPases in the ER. In contrast, none
of the four human P5B ATPases, nor Ypk9p, were able to complement the caffeine sensitivity
of spf1- cells (Fig 6A).
It was already reported that ATP13A2 fails to complement the ypk9- deletion strain [5, 10].
Moreover, none of the four mammalian P5B ATPases were able to rescue the Mn2+ sensitivity
of the ypk9- strain (Fig 6B). This deficiency may be due to lack of expression or cellular mis-
localization in the heterologous expression system. To investigate this, GFP-labeled Ypk9p and
ATP13A1-5 were expressed in yeast and we observed that Ypk9p-, ATP13A2- and
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ATP13A4-GFP constructs were clearly targeted to the vacuole (the counterpart of the mam-
malian lysosomal compartment) (Fig 6D and 6E). The failure of the mammalian P5B ATPases
to complement the yeast ypk9- deletion strain, despite the fact that they were expressed and tar-
geted to the same membrane system as Ypk9p, may support the view that the animal and yeast
P5B ATPases may have evolved different cellular functions or may be regulated differently.
Discussion
In this study, we compared the properties and relationship of the five mammalian P5-type
ATPase gene products, ATP13A1-5, for which the function is not yet established.
Fig 6. Genetic complementation in yeast with mammalian P5-type ATPases. The genome of S. cerevisiae contains a single P5A ATPase gene (SPF1) and a
single P5B ATPase gene (YPK9). A. Gene knockout of SPF1 results in increased sensitivity to caffeine which can be rescued by expression of untagged Spf1p
and mATP13A1 respectively, but not by the untagged catalytically dead SPF1 D487N or by untagged mammalian ATP13A2-5. (e.v.–empty vector) B.
Deletion of ypk9- results in increased sensitivity to MnCl2, which can be rescued by expression of untagged Ypk9p, but not by the untagged and catalytically
dead Ypk9p D781N. None of the untagged mammalian P5 ATPase genes showed rescue of ypk9- (not shown). C. ATP13A1 complements the caffeine
phenotype of the spf1- knockout strain, whereas the catalytically dead mutant D530N fails to complement. D. Expression of Ypk9p and catalytically dead
Ypk9p D781N proteins was confirmed by both N-terminal GFP fusion constructs. Ypk9p tagged with GFP show vacuolar localization. E. Expression of
mammalian ATP13A1-5 proteins was similarly confirmed by N- and C-terminal GFP fusion constructs. N- or C-terminal positioning of GFP showed no
apparent difference in localization patterns. ATP13A1 shows ER localization and is absent in vacuoles, ATP13A2 and ATP13A4 show vacuolar localization,
ATP13A3 and ATP13A5 show localization to cytosolic spots which could represent a pre-vacuolar compartment or early endosomes. Scale bars represent
2,5 μm.
https://doi.org/10.1371/journal.pone.0193228.g006
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Our phylogenetic analysis subdivides the animal P5-type ATPase into a P5A (ATP13A1)
and P5B (ATP13A2-5) group, which may reflect fundamental differences in cellular function.
The distinction between P5A and P5B already appeared early in eukaryote evolution [44, 53]
and here we provide further support for this clear distinction based on differences in subcellu-
lar localization, membrane topology and functional complementation in yeast. The presence
of charged versus uncharged residues in the M4 helix at the position of the putative substrate
binding site (PP(E/D)xPx(E/D) versus PP(A/V)xP(A/V)x motif in P5A and P5B, respectively)
possibly indicates that members of the two groups transport different substrates [44, 53]. All
animal species contain exactly one P5A member, whereas additional P5B isoforms appeared in
vertebrate evolution (ATP13A2-5) after successive gene duplications, with ATP13A2 being the
oldest representative. An important question is whether these various P5B isoforms may fulfill
similar cellular roles. The conserved putative substrate-binding motif in ATP13A2-5 indicates
that the vertebrate P5B isoforms may transport the same or a closely related ligand. Instead,
based on their expression pattern and subcellular localization, the various P5B-ATPases may
exert tissue-specific functions and/or may fulfill overlapping roles in sub-compartments of the
endosomal system. The P5B isoform diversity in higher vertebrates seems to be particularly
relevant in the brain, where all isoforms are co-expressed. Also, the dysfunction of ATP13A2
and ATP13A4 are linked to various neurological disorders.
To get closer to answering these questions, we cloned several mammalian P5B isoforms for
the first time, generated molecular tools and protocols for their study and optimized the first
biochemical assays, which will facilitate further research. So far, we observed autophosphoryla-
tion of the ATP13A1-4 isoforms without adding a particular ligand to stimulate activity. This
may indicate that the transported ligand of the P5 ATPases is membrane associated or that the
P5 ATPases undergo autophosphorylation prior to the binding of their substrate, similar to
what is observed for the P4-type ATPases [1, 4].
P5A ATPases exert a highly conserved ER function
We show with various complementary methods using tagged and untagged protein that the
mammalian ATP13A1 isoform is an ER resident protein. Irrespective of the tag and species
(mammalian versus yeast cells) we observed a clear reticular ER distribution for ATP13A1.
This pattern is not merely a result of improper folding of ATP13A1 due to the overexpression.
Indeed, we demonstrated via biochemical and complementation assays that ATP13A1 remains
functional. The ER distribution for ATP13A1 is similar to the localization of other P5A ortho-
logues in Saccharomyces pombe [58] and Arabidopsis thaliana [59]. The S. cerevisiae orthologue
Spf1p resides in the ER membrane [17, 60], but may also be found in cis-Golgi membrane frac-
tions [61]. The P5A ATPases appear to play an essential role in the ER, since all animal
genomes typically contain a single highly conserved P5A ATPase gene. Moreover, like the bar-
ley HvP5A1 isoform [12], the mammalian ATP13A1 isoform complements loss of SPF1 in
yeast showing that P5A-type ATPases exert identical or overlapping ER functions across differ-
ent species. Thus, our results demonstrate that the already established yeast spf1- phenotype
will provide key information on the physiological role of ATP13A1 in mammalian cells,
whereas ATP13A1 functionality can be studied in yeast.
The exact role of the P5A ATPases in the ER remains unidentified, but several ER-related
properties are affected by the loss of SPF1 in yeast. Loss of the SPF1 gene influences the
unfolded protein response [62], the insertion of tail-anchored or transmembrane proteins into
the membrane and it controls the topology of integral membrane proteins [63–65]. Further-
more, spf1 affects the glycosylation of secreted proteins [60, 66–69], the translocation of secre-
tory proteins across the ER membrane [66, 67, 70, 71] and vesicle trafficking [66, 67, 70–72].
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Finally, deletion of spf1 impairs the biosynthesis and transport of sterols [17, 65, 73] and may
be implicated in Ca2+ homeostasis [3, 12, 73, 74]. Our complementation results indicate that
ATP13A1 may play a similar physiological role as Spf1p and may therefore also be involved in
these processes in mammalian cells.
The ATP13A2-5 isoforms may fulfill partially overlapping functions in the
endo-/lysosomes
Our results show that the ATP13A2-4 isoforms are targeted to overlapping compartments of
the endosomal system, which differs from the ER localization of P5A ATPases. The late endo-/
lysosomal localization of ATP13A2 in mammalian cells [19] and the targeting of Ypk9p in S.
cerevisiae to the vacuole, the equivalent organelle of the lysosomes in yeast were already
described [5]. Further in line with a late endo-/lysosomal function, ATP13A2 deficiency in
fibroblasts derived from Kufor Rakeb disease patients [16] causes an increase in size and num-
ber of lysosomes, diminished lysosomal-mediated clearance of autophagosomes and impaired
lysosomal degradation [75]. Whether loss of ATP13A3-5 function may lead to a similar endo-/
lysosomal phenotype needs further investigation, but the presence of multiple P5B isoforms in
overlapping endosomal sub-compartments indicates that the P5B ATPases may fulfill partially
redundant functions, although each isoform displays a slightly different endosomal targeting.
ATP13A2 is predominantly found in late endo-/lysosomes, ATP13A3 in recycling endosomes
and ATP13A4 displays a broader distribution.
The targeting to the endosomes may not be general for all P5B-ATPase orthologues. One of
the C. elegans P5B orthologues CATP-5 is associated with the plasma membrane [76]. Also, a
previous study reported the targeting of ATP13A4 to the ER [39], although here we clearly
observe an endosomal distribution of ATP13A4, indicating that targeting motifs for the endo-
cytic compartment must be present. The discrepancy for ATP13A4 may relate to differences
in cell type and expression of co-factors important for the targeting or the level of overexpres-
sion. Unfortunately, we were unable to observe reproducible expression, localization or activ-
ity of ATP13A5 in different cell models. We verified that the cDNA sequence corresponds to
the reported sequence in the gene database dbEST (accession number Q3TYU2.2) and we
tested two independent cDNA constructs obtained by two commercial vendors. Since
ATP13A5 displays a more restricted tissue distribution than other P5 ATPases [42], the stable
ATP13A5 expression and subcellular targeting may require a specific cell type, expressing aux-
iliary proteins or containing essential co-factors or substrates.
The subcellular localization of tagged ATP13A1-5 proteins in an overexpression system
may not necessarily reflect the localization of the endogenous proteins. However, we could
exclude that the tag or the protein activity interfered with the targeting as we observed a similar
subcellular distribution for various N- and C-terminal fusion proteins and inactive proteins,
and no signs of abnormalities in the endosomal system were found. Still, the overexpression
may saturate subcompartments of the endo-/lysosomal system that may result in a slightly
broader endosomal distribution as compared to the endogenous protein, which is reflected by
our PCC values. This was previously reported for ATP13A2, but the differences between
endogenous and overexpressed ATP13A2 were subtle [11] and the conclusion that ATP13A2
is targeted to late endo-/lysosomes remains valid. This suggests that the overexpression system
provides a good approximation to determine the intracellular targeting, but future studies with
high quality antibodies will be required to confirm the localization on the endogenous
proteins.
Based on our FPP analysis, we can conclude that the topology of the N-terminal regions of
ATP13A2-4 is highly similar, but different from ATP13A1, as our FPP analysis only deals with
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the topology of the N-terminus, and other TM regions were not verified by this approach.
However, sequence alignments and topology predictions of the P5-type ATPases already indi-
cated that all P5 isoforms have 10 TM helices the core protein in common with other P2, P3
and P4-type ATPases [53]. The P5 ATPases only differ at their N-terminus by harboring an
additional hairpin motif (P5A) or a conserved hydrophobic region Ma that is not spanning the
membrane (P5B). For all P5B ATPases, Ma is similar in size and composition and contains a
highly conserved Gly residue. This Gly residue may introduce a kink in the membrane associ-
ated region in order to keep the hydrophobic segment at the cytosolic membrane leaflet, as
was demonstrated for ATP13A2 [37].
As none of the mammalian P5B isoforms did complement the Mn2+ toxicity phenotype of
the yeast ypk9- deletion strain, we were unable to draw any conclusions on the functional rela-
tionship between the animal and fungal proteins. The mammalian P5B isoforms may not be
functional in yeast due to the lack of regulatory mechanisms, post-translational modifications
or dependence on other co-factors. However, this negative result may also indicate that the
substrate specificity of the animal P5B ATPases is different from the yeast P5B, questioning
whether yeast is a good host to evaluate the mammalian P5B function. The evolution of the
P5B-type ATPases is marked by multiple parallel gene duplication/deletion events and rapid
diversification, making it difficult to unambiguously assess the phylogenetic and functional
relationship between vertebrate ATP13A2 and ATP13A3, or between yeast, vertebrate and
invertebrate P5B orthologues. To assess the functional relationship in the future, complemen-
tation experiments may be conducted in animal model organisms, like C. elegans, D. melano-
gaster or D. rerio. It is clear from our phylogenetic analysis that invertebrate P5B isoforms
group in a different clade than the vertebrate isoforms, possibly indicating that their functions
may have diverged. Therefore, vertebrate models may be required to study the relationship of
the four mammalian P5B isoforms.
In conclusion, we provide a comprehensive comparison of the molecular properties and
relationship of the five mammalian isoforms ATP13A1-5. Based on a phylogenetic analysis
and supported by a distinct subcellular targeting, topology and functional complementation
potential, we provide strong support for the division of the animal P5-type ATPases into a P5A
and P5B group. The P5A most likely carries out a general cellular function in the ER related to
protein folding and quality control, whereas P5B ATPases have evolved cell-specific functions
in the late endo-/lysosomal network. Evolution of animals has been accompanied not only by
development of a central nervous system, but also by the appearance of specialized epithelial
glandular cells that are essential for diverse functions such as slime production in lungs to milk
secretion, which strongly depend on an endo-/lysosomal system to carry out extensive exo-
and endocytosis. Further studies will have to reveal the specific roles of P5B ATPases in shap-
ing evolution and development of animals.
Supporting information
S1 Fig. Overview of P5B gene duplication events in animal evolution. The phylogenetic tree
depicts (1) Gene duplication in deuterostomia evolution of the P5BANCESTOR orthologue
resulted in an ATP13A2 and ATP13A3 isoform. A single P5BINV isoform (invertebrates) is
present in most protostomia species. (2) Gene duplication of ATP13A3 into an ATP13A3 and
ATP13A4 isoform. (3) Gene duplication of ATP13A4 into an ATP13A4 and ATP13A5 iso-
form.
(PDF)
S2 Fig. Tissue distribution of P5-type ATPase mRNA expression. Analysis of publically
available mRNA expression data shows a P5-type ATPase expression profile that is tissue and
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development specific in human and mouse. A. Comparing expression of ATP13A1-5 mRNA
in human tissue samples shows a general presence of ATP13A1 and ATP13A3 mRNA across
all tissues with lower expression in muscoskeletal muscle (ATP13A1 and ATP13A3) and ner-
vous and reproductive systems (ATP13A3). ATP13A2 strongly expresses in the nervous sys-
tem, whereas ATP13A4 is mainly expressed in the respiratory systems (lungs, pharynx,
trachea) and integumentary system (skin and epidermis) while ATP13A5 strongly express in
the sensory organs (eye and nose) and integumentary systems. Number of samples included
for each tissue is included on the right. B. During mouse development, ATP13A3 appears to
be strongly expressed at the early prenatal period (2–4 days of development), while ATP13A4
and ATP13A5 mRNA shows expression in the post-natal period. Only developmental data for
ATP13A3-5 are depicted, because only these isoforms show differential expression during
development. C-D. Expression profiles of ATP13A4 and ATP13A5 mRNA in human cell and
tissue samples. Only the tissues with the highest expression are shown. Both genes express
highly in cuboidal alveolar type 2 cells (black arrow) and in tissues of the sexual organs (light
grey arrows: ATP13A4 epididymal corpus in testis, ATP13A5 mammary gland of the breast).
ATP13A4 express highly in the oral mucosa and gingiva of the mouth (light blue arrows).
ATP13A5 shows a general high expression in epidermis and dermis cells but also shows spe-
cific expression in the nasal epithelium and cells of nasal organotypic tissue cultures (dark blue
arrows). ATP13A1-3 show a much broader tissue distribution and are not depicted.
(PDF)
S3 Fig. Purification of yeast Ypk9p (WT and D781N). A-B. The N-terminal 10xHis-tagged
versions of Ypk9p (A) and Ypk9 (D781N) (B) were purified to relative homogeneity as
described in materials and methods by utilizing Ni2+ affinity chromatography. The resulting
proteins were found at the expected size of ~170 kDa at high purity. 15 μl of sample for each
fraction during purification was separated using SDS-PAGE and visualized with Coomassie
blue staining. Flowthrough (FT), wash (W1-4), elution (E1-4) and marker (Mk) is indicated.
(PDF)
S4 Fig. Characterization of the affinity-purified ATP13A1 antibody for immunoblotting.
A. Topology model of ATP13A1 indicating the peptide recognition sequences of the
ATP13A1 SY2459 (AA 543–557 in hATP13A1) B-C. Microsomal fractions of COS-8 cells
transiently transfected with ATP13A1 or ATP13A1 fusion proteins (N-terminal GFP-tag)
were applied. As a negative control, the microsomal fraction of non-transfected COS-8 cells
was loaded. Blots were incubated with ATP13A1 SY2459 antibody, which recognizes full-
length mATP13A1 (133 kDa). In (C) blots were incubated with the antibody in absence or
presence of excess quantities of the immunizing peptide.
(PDF)
S5 Fig. Catalytic dead mutants display similar targeting as WT proteins. A. The catalytically
inactive ATP13A1 mutant D530N is targeted to the ER, overlapping with the ER marker SER-
CA2b. B. Like WT ATP13A2, the catalytically inactive mutant hATP13A2-D508N reaches the
late endosomal compartment (visualized with GFP-labeled RAB7). Scale bar represents 20 μm.
(PDF)
S6 Fig. ATP13A1 contains an additional N-terminal hairpin. A. Predicted topology model
of ATP13A1 with 12 TM helices (M) (TMHMM v2). On top of the figure, the numbering of
membrane helices is indicated: M1 corresponds to the first M helix that is present in all P-type
ATPases, whereas more upstream helices are referred to as Ma and Mb, with Mb the most N-
terminal helix. B-L. Fluorescence protease protection assay. In HeLa cells, WT ATP13A1 with
N- (D) or C-terminal (E) GFP-tag, Mb-Ma-C-GFP (residues 1–197) (I), Mb-C-GFP (residues
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1–95) (J) or controls (ERO-GFP (C) or GFP (B) were transiently transfected and subjected to
FPP. Pictures at 0’, 3’ and 5’ are depicted. Numbers in circles correspond to positions indicated
in the cartoons F-H. + and–in circles indicate positive or negative control. F. Experimentally
verified topology model of ATP13A1 depicting 12 TM helices. G-H. Cartoon depicting the Ma
and Mb-Ma constructs (in the cartoon, a C-terminal GFP-tag is indicated). K-L. HeLa cells
were transiently co-transfected with Mb (C-terminal mCherry-tag) or Mb-Ma (C-terminal
GFP-tag) and different cellular markers. Mb co-localizes with Rab7, a marker for late endo-/
lysosomes (K), whereas Mb-Ma co-localizes with SERCA2b, an ER resident protein. Scale bar
represents 40 μm (B-J) or 20 μm (K-L).
(PDF)
S7 Fig. The P5B ATPases ATP13A3 and ATP13A4 share topology with ATP13A2. A.
Topology model of ATP13A2 comprising 10 TM helices and one membrane-associated helix,
not spanning the membrane. B-E. Fluorescence protease protection (FPP) assay. WT
ATP13A3 (N- (B) or C-terminal (C) GFP-tag) or WT ATP13A4 (N- (D) or C-terminal (E)
GFP-tag) were transiently transfected in HeLa cells and subjected to FPP. Pictures were
acquired at 0’, 3’ and 5’. Numbers in circles correspond to the position of the GFP-tag in (A).
Scale bar represents 40 μm.
(PDF)
S8 Fig. Complementation assay with GFP-labeled ATP13A1 constructs. Both the N- and C-
terminal GFP labeled ATP13A1 constructs provide a functional complementation of the spf1-
deletion phenotype in yeast. This is not seen with a catalytic dead mutant of ATP13A1
(D530N). This proves that the N- and C-terminal fusion constructs remain functionally active
and are not affected by the tag.
(PDF)
S1 Table. Accession numbers of sequences included in the phylogenetic analysis. Sequence
information of the P5 isoforms included in the phylogenetic analysis of Figs 1 and 2. n.s. not
specified; A1, P5A isoform; B1-5, number of P5B isoforms per species; P5BINV, P5B inverte-
brates.
(PDF)
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